UKHCDO LIMITED

	Page
Abridged Balance Sheet	1—2
Notes to the Abridged Financial Statements	3—5

Registered number: 05768634

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		39,606		44,740
Investments	5		1,394,478		1,388,795

			1,434,084		1,433,535
CURRENT ASSETS
Stocks	6	439,947		92,289
Debtors		200,274		200,357
Cash at bank and in hand		649,933		958,206

		1,290,154		1,250,852
Creditors: Amounts Falling Due Within One Year		(256,934 )		(181,284 )

NET CURRENT ASSETS (LIABILITIES)			1,033,220		1,069,568

TOTAL ASSETS LESS CURRENT LIABILITIES			2,467,304		2,503,103

NET ASSETS			2,467,304		2,503,103

CAPITAL AND RESERVES
Called up share capital	7		1		1
Profit and Loss Account			2,467,303		2,503,102

SHAREHOLDERS' FUNDS			2,467,304		2,503,103

Page 1

Page 2

UKHCDO LIMITED

Abridged Balance Sheet (continued)

As At 31 March 2025

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 31 March 2025 in accordance with section 444(2A) of the Companies Act 2006.

The financial statements were approved by the board of directors on 6 June 2025 and were signed on its behalf by:

Professor Charles Hay

Director

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

UKHCDO LIMITED is a private company, limited by shares, incorporated in England & Wales.

The registered number 05768634 .

The registered office is Suite 1 On Part 2nd Floor Anchorage One, Anchorage Quay, Salford Quays, Salford, M50 3YJ.

No dividends were paid in the year and none are proposed.

Related party transactions are reported in the notes to the accounts.

There are no other related party transactions to report.

There are no contingent liabilities to report.

There are no post balance sheet events to report.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover represents net invoiced sales of services and sponsorship monies receivable excluding Value Added Tax (VAT).

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are stated at cost less accumulated depreciation.

Depreciation is provided on reducing balance basis at the following annual rates in order to write off each asset over its estimated useful life.

Plant & Machinery	5% Reducing Balance
Fixtures & Fittings	15% Reducing Balance

No depreciation is charged in the year of acquisition.

2.4. Stocks and Work in Progress

Work in progress has been valued at prime cost of labour and other direct expenses.

2.5. Pensions

The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.

2.6. Government Grant

Grants and donations received relate to contributions by major pharmaceutical entities towards the costs of the National Haemophilia Database 2 development project.

The costs of this project are expensed in the year in which they are incurred.

All grants in the profit and loss account are recognised immediately as other operating income in the year in which they are received.

2.7. Donations

Donations made are charged as an expense in the year in which they are made.

2.8. Investments & Investment Income

Investments are stated at mid-market value at the balance sheet date.

Unrealised investment gains and losses are calculated as the difference between the valuation at the balance sheet date and their valuation at the last balance sheet date or purchase price, if acquired during the year.

Investment income comprises investment income, realised and unrealised investment gains and losses less investment expenses.

Realised investment gains and losses are calculated as the difference between net proceeds on disposal and their purchase price.

2.9. Research and Development

Expenditure on research and development is written off against the profits in the year in which it is incurred.

2.10. Registrar Filing Requirements

The company has taken advantage of Companies Act 2006 section 444(1) and opted not to file the profit and loss account, directors report, and notes to the financial statements relating to the profit and loss account.

Page 3

Page 4

UKHCDO LIMITED

Notes to the Abridged Financial Statements (continued)

For The Year Ended 31 March 2025

3. Average Number of Employees

The average number of full time employees during the year was as follows:

There are eight Directors who are all unpaid and do not have contract of service agreements relating to their appointment.

	2025	2024
Office and administration	10	8

	10	8

4. Tangible Assets

	Total
	£
Cost
As at 1 April 2024	58,388
Additions	1,272

As at 31 March 2025	59,660

Depreciation
As at 1 April 2024	13,648
Provided during the period	6,406

As at 31 March 2025	20,054

Net Book Value
As at 31 March 2025	39,606

As at 1 April 2024	44,740

5. Investments

	Total
	£
Cost or Valuation
As at 1 April 2024	1,388,795
Additions	26,634
Revaluations	(20,951 )

As at 31 March 2025	1,394,478

Provision
As at 1 April 2024	-

As at 31 March 2025	-

Net Book Value
As at 31 March 2025	1,394,478

As at 1 April 2024	1,388,795

6. Stocks

	2025	2024
	£	£
Work in progress	439,947	92,289

Page 4

Page 5

UKHCDO LIMITED

Notes to the Abridged Financial Statements (continued)

For The Year Ended 31 March 2025

7. Share Capital

	2025	2024
Allotted, called up and fully paid	£	£
1 Ordinary Shares of £ 1.00 each	1	1

8. Pension Commitments

The company operates a defined contribution pension scheme.

The assets of the scheme are held separately from those of the company in an independently administered fund. At the balance sheet date contributions of £Nil (2024 £Nil) were due to the fund and these amounts are included in Other Creditors.

9. Related Party Transactions

Transactions with Controlling Party

The Company runs meetings sponsored by pharmaceutical firms on behalf of UKHCDO (Registered Charity Number 1032606). Any surplus made by the Company on running meetings is donated to UKHCDO.

A gift of £50,000 (2024 £50,000) was made in the year to UKHCDO. The funding of UKHCDO is substantially derived from gifts made by UKHCDO Limited.

10. Ultimate Controlling Party

The Company is wholly owned by UKHCDO (Registered Charity Number 1032606) and is therefore controlled by the Trustees of UKHCDO.

- Prof. Pratima Chowdary Mamillapalli served as a Trustee of UKHCDO throughout the year.

- Dr. Katherine Talks served as a Trustee of UKHCDO throughout the year.

- Dr. Gary Benson served as a Trustee of UKHCDO throughout the year.

- Dr. Mary Mathias served as a Trustee of UKHCDO throughout the year.

Page 5